Faber J, Kirkegaard C, Lumholtz I B, Siersbaek-Nielsen K, Friis T
J Clin Endocrinol Metab. 1982 Jul;55(1):8-12. doi: 10.1210/jcem-55-1-8.
Simultaneous kinetic studies of 3,5-diiodothyronine (3,5-T2) and T3 were performed in 15 healthy controls (8 men and 7 women), 7 hyperthyroid patients (2 men and 5 women), and 6 hypothyroid women using the single injection, noncompartmental approach. The serum concentrations (picomoles per liter), MCRs (liters . day-1 . (70 kg)-1), and production rates (PRs; nmol . day-1 . (70 kg)-1) of 3,5-T2 in healthy men and women were (mean +/- SD): 100 +/- 23 vs. 80 +/- 23 (P = NS), 59 +/- 31 vs. 123 +/- 58 (P less than 0.025), and 5.6 +/- 1.9 vs. 9.1 +/- 2.6 (P less than 0.02). The conversion rate (CR) of T3 to 3,5-T2 was 12.0 +/- 3.8% in men compared to 18.5 +/- 3.7% in women (P less than 0.01). Serum 3,5-T2 levels in five mildly hyperthyroid women were elevated to 123 +/- 33 pmol/liter (P less than 0.05), whereas the MCR and PR were unchanged. However, two hyperthyroid men with more pronounced elevation of serum T3 had enhanced PRs (26.9 and 23.9 nmol . day-1 . (70 kg)-1). The CR in hyperthyroid women was significantly reduced to 5.6 +/- 2.9% (P less than 0.001). The serum levels, MCR, and PR of 3,5-T2 in hypothyroid women were: 58 +/- 25 pmol/liter (P = NS), 71 +/- 52 liters . day-1 . (70 kg)-1 (P = NS), and 3.4 +/- 2.4 nmol . day-1 . (70 kg)-1 (P less than 0.005). The CR was enhanced to 34.8 +/- 15.7% (P less than 0.05). Our data demonstrate that in euthyroid subjects, approximately 15% of T3 is deiodinated to 3,5-T2, and this 5'-deiodination of T3 is influenced by thyroid function.
采用单次注射、非房室分析方法,对15名健康对照者(8名男性和7名女性)、7名甲状腺功能亢进患者(2名男性和5名女性)以及6名甲状腺功能减退女性进行了3,5 - 二碘甲状腺原氨酸(3,5 - T2)和T3的同步动力学研究。健康男性和女性的3,5 - T2血清浓度(皮摩尔/升)、MCR(升·天⁻¹·(70千克)⁻¹)和生成率(PR;纳摩尔·天⁻¹·(70千克)⁻¹)分别为:100±23 对 80±23(P = 无显著性差异),59±31 对 123±58(P<0.025),以及 5.6±1.9 对 9.1±2.6(P<0.02)。T3向3,5 - T2的转化率(CR)在男性中为 12.0±3.8%,而在女性中为 18.5±3.7%(P<0.01)。5名轻度甲状腺功能亢进女性的血清3,5 - T2水平升高至 123±33 皮摩尔/升(P<0.05),而MCR和PR未改变。然而,2名血清T3升高更明显的甲状腺功能亢进男性的PR有所升高(分别为 26.9 和 23.9 纳摩尔·天⁻¹·(70千克)⁻¹)。甲状腺功能亢进女性的CR显著降低至 5.6±2.9%(P<0.001)。甲状腺功能减退女性的3,5 - T2血清水平、MCR和PR分别为:58±25 皮摩尔/升(P = 无显著性差异),71±52 升·天⁻¹·(70千克)⁻¹(P = 无显著性差异),以及 3.4±2.4 纳摩尔·天⁻¹·(70千克)⁻¹(P<0.005)。CR升高至 34.8±15.7%(P<0.05)。我们的数据表明,在甲状腺功能正常的受试者中,约15%的T3脱碘生成3,5 - T2,且T3的这种5' - 脱碘受甲状腺功能影响。